CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Nanobiotix Sa Company Snapshot
Nanobiotix Sa operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nanobiotix Sa with three other miscellaneous service companies in Europe: Genomic Vision Sa (2016 sales of 1.56 million Euro [US$1.68 million] ), Oxford Biodynamics PLC of the United Kingdom (£1.09 million [US$1.36 million] of which 100% was Pharmaceutical), and Nanorepro AG which is based in Germany (1.55 million Euro [US$1.67 million] ).

Sales Analysis. Sales increased substantially in 2016: During the year ended December of 2016, sales at Nanobiotix Sa were 1.56 million Euro (US$1.68 million). This is an increase of 486.8% versus 2015, when the company's sales were 265,543.00 Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Nanobiotix Sa
  Stock Performance Chart for Nanobiotix Sa
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 17.03
(Figures in Euro)
1 Week 7.0%   13 Weeks 12.9%  
4 Weeks 12.8%   52 Weeks -1.2%  
 
Nanobiotix Sa Key Data:
  Ticker: NANO Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 1,558,100
(Year Ending Jan 2017).
Employees: 31
  Currency: Euro Market Cap: 266,094,397
  Fiscal Yr Ends: December Shares Outstanding: 15,625,038
  Share Type: Ordinary Closely Held Shares: 1,721,442
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.